VERRICA PHARMACEUTICALS INC (VRCA) Stock Income Statement
NASDAQ:VRCA - Nasdaq - US92511W1080 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.18M | 7.57M | 5.12M | 9.03M | 12.00M | |||
| Cost Of Goods | 2.04M | 2.74M | 746.00K | 730.00K | N/A | |||
| Gross Profit | 5.14M | 4.83M | 4.38M | 8.31M | N/A | |||
| Operating Expenses | 60.51M | 70.66M | 67.60M | 29.60M | 42.91M | |||
| Research and Development | 9.18M | 11.84M | 20.30M | 12.20M | 15.93M | |||
| Selling, General, and Administrative Expenses | 51.33M | 58.82M | 47.30M | 17.41M | 26.98M | |||
| Operating Income | -55.37M | -65.84M | -63.22M | -21.29M | -30.91M | |||
| Interest Income/Expense | -10.53M | -10.64M | -1.22M | -1.70M | -4.17M | |||
| Other Income/Expense | -6.00K | -17.00K | -14.00K | -60.00K | N/A | |||
| Non Recurring Items | N/A | -83.00K | -2.54M | -1.44M | N/A | |||
| Income Before Taxes | -65.99M | -76.58M | -67.00M | -24.49M | -35.08M | |||
| Income Tax | N/A | 0.00 | N/A | 0.00 | N/A | |||
| Net Income | -65.99M | -76.58M | -67.00M | -24.49M | -35.08M | |||
| EBITDA | -54.15M | -64.57M | -62.39M | -20.84M | -30.67M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.20 | -1.48 | -1.48 | -0.72 | -1.30 | |||
| Non GAAP EPS | -1.20 | -1.54 | -1.46 | -0.79 | -1.29 | |||
| Statistics | ||||||||
| Gross Profit Margin | 71.60% | 63.79% | 85.44% | 92.03% | N/A | |||
| Profit Margin | -919.21% | -1012.15% | -1307.47% | -271.21% | -292.33% | |||
| Operating Profit Margin | -771.24% | -870.16% | -1233.84% | -235.77% | -257.58% | |||
All data in USD